- Home
- / Aadi Bioscience
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Aadi Bioscience financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
$24.4 M
FY, 2023
CreditSafe Score
?
Score changed on Jun 13, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 20.2M | 15.0M | 1.1M | 15.2M | 24.4M | ||||||||
| Cost of goods sold | 1.3M | 2.8M | |||||||||||
| Gross profit | 13.9M | ||||||||||||
| Gross profit margin, % | 91.2% | ||||||||||||
| General and administrative expense | 23.6K | 22.4K | 22.8K | 24.0K | 23.0K | 29.5K | 9.2M | 13.5M | 9.8M | 8.8M | 18.5M | 40.2M | 44.5M |
| Operating expense total | 23.6K | 22.4K | 22.8K | 24.0K | 23.0K | 29.5K | 21.4M | 31.3M | 22.6M | 21.4M | 38.2M | 76.6M | 93.5M |
| EBIT | (23.6K) | (22.4K) | (22.8K) | (24.0K) | (23.0K) | (29.5K) | (21.4M) | (11.2M) | (24.4M) | (6.4M) | (111.2M) | (62.7M) | (71.9M) |
| EBIT margin, % | -55.5% | -42.4% | -9930.1% | -411.9% | |||||||||
| Interest income | 13.0K | 2.4M | 6.4M | ||||||||||
| Interest expense | 3.6K | 5.0K | 5.9K | 6.8K | 8.4K | 9.9K | 105.8K | 778.2K | 1.0M | 147.8K | 665.0K | 230.0K | 231.0K |
| Pre tax profit | (110.1M) | (60.5M) | (65.8M) | ||||||||||
| Income tax expense | 2.0K | ||||||||||||
| Net Income | (27.2K) | (27.4K) | (28.7K) | (30.8K) | (31.4K) | (39.4K) | (21.4M) | (10.4M) | (23.3M) | (4.3M) | (110.1M) | (60.5M) | (65.8M) |
| EPS | (2.7) | (2.0) |